More

    Tag: CRO

    Adam Kapel: A Strategic Architect of B2B Tech Storytelling and Growth

    Adam Kapel is a seasoned marketing and growth strategist with over three decades of experience in shaping compelling narratives and driving brand differentiation for B2B technology companies. As a former CMO, CGO, and CRO, he has led marketing, sales, and account teams across industry-leading organizations, refining their positioning and accelerating revenue growth. Now, in his semi-retired advisory role at **KAP: Kapel Advisory + Production**, Adam is dedicated to coaching the next generation of marketing and sales leaders while continuing to craft impactful, client-centric stories that set businesses apart. His expertise lies in transforming complex ideas into clear, engaging narratives that resonate with customers, fuel engagement, and drive sustainable success in competitive markets.

    Peter Payne: Distinguished Executive Leader in Biopharmaceuticals and CRO Industries

    Peter Payne is a highly accomplished executive with over 30 years of leadership experience in the pharmaceutical, biotechnology, and contract research organization (CRO) industries. Known for his integrity and results-driven approach, Peter has successfully led organizations through periods of significant growth and transformation. With deep expertise in drug development, clinical trials, and corporate strategy, he has built a strong reputation for driving innovation and strategic partnerships. His leadership spans notable roles, including Vice President at Optum, President of Gennaker Bio, and CEO at multiple biotech companies. Peter’s ability to communicate complex strategies and foster cross-functional collaboration has made him a respected figure in the life sciences industry.

    Quynh Ton: Sr Business Development Manager in Biotechnology

    Quynh Ton is a dedicated and resilient molecular and cellular developmental biologist with over 10 years of experience in the biotech industry. Known for her integrity and commitment to improving patient care, Quynh combines her extensive knowledge in drug discovery, gene therapy, and antibody development with a proven track record in business development. She has successfully secured significant contracts, demonstrating her strategic acumen and ability to drive initiatives within her field. Quynh's exceptional communication skills enable her to convey complex scientific concepts clearly, fostering collaboration across diverse teams and stakeholders. Her passion for advancing scientific knowledge and delivering impactful solutions positions her as a valuable asset in any organization.